Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 7
Submit an article Journal homepage
633
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells

Mark B. GeyerDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA; ;Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York City, NY, USA; ORCID Iconhttp://orcid.org/0000-0001-5248-9117
ORCID Icon,
Shwetha H. ManjunathDepartment of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA;
,
Andrew G. EvansDepartment of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA;
,
Jae H. ParkDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA; ;Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York City, NY, USA;
,
Marco L. DavilaH. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA;
,
Corey S. CutlerDivision of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, MA, USA;
,
Xiuyan WangCenter for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York City, NY, USA;
,
Yongzeng WangMichael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York City, NY, USA;
,
Brigitte SenechalMichael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York City, NY, USA;
,
Isabelle RivièreCenter for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York City, NY, USA; ;Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York City, NY, USA;
,
Michel SadelainCenter for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York City, NY, USA;
,
Jane L. LiesveldDepartment of Medicine, Hematology Oncology Division, Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
&
Renier J. BrentjensDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA; ;Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York City, NY, USA; Correspondence[email protected]
 show all
Pages 1717-1721 | Received 30 Sep 2017, Accepted 02 Oct 2017, Published online: 18 Oct 2017

References

  • Davila ML, Riviere I, Wang X, et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med. 2014;6:224ra225.
  • Maude SL, Frey N, Shaw PA, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014;371:1507–1517.
  • Porter DL, Hwang WT, Frey NV, et al. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci Transl Med. 2015;7:303ra139.
  • Turtle CJ, Hanafi LA, Berger C, et al. CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients. J Clin Invest. 2016;126:2123–2138.
  • Turtle CJ, Hay KA, Hanafi LA, et al. Durable molecular remissions in chronic lymphocytic leukemia treated with CD19-specific chimeric antigen receptor-modified T cells after failure of ibrutinib. J Clin Oncol. 2017;35:3010–3020.
  • Wetzler M, Sanford BL, Kurtzberg J, et al. Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: cancer and Leukemia Group B Study 9511. Blood. 2007;109:4164–4167.
  • Hollyman D, Stefanski J, Przybylowski M, et al. Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy. J Immunother. 2009;32:169–180.
  • Chakhachiro Z, Yin CC, Abruzzo LV, et al. B-lymphoblastic leukemia in patients with chronic lymphocytic leukemia: a report of four cases. Am J Clin Pathol. 2015;144:333–340.
  • Mohamed AN, Compean R, Dan ME, et al. Clonal evolution of chronic lymphocytic leukemia to acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1996;86:143–146.
  • Pistoia V, Roncella S, Di Celle PF, et al. Emergence of a B-cell lymphoblastic lymphoma in a patient with B-cell chronic lymphocytic leukemia: evidence for the single-cell origin of the two tumors. Blood. 1991;78:797–804.
  • Ramsay AG, Clear AJ, Fatah R, et al. Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer. Blood. 2012;120:1412–1421.
  • Riches JC, Davies JK, McClanahan F, et al. T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production. Blood. 2013;121:1612–1621.
  • Fraietta JA, Beckwith KA, Patel PR, et al. Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia. Blood. 2016;127:1117–1127.
  • Pegram HJ, Lee JC, Hayman EG, et al. Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning. Blood. 2012;119:4133–4141.
  • Zhao Z, Condomines M, van der Stegen SJ, et al. Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T cells. Cancer Cell. 2015;28:415–428.
  • McClanahan F, Hanna B, Miller S, et al. PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia. Blood. 2015;126:203–211.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.